Students glimpse the future


Cambridge, UK, [31 March 2017]: A group of STEM ‘A’ level students from Jack Hunt School in Peterborough have been given rare access to the state-of-the-art surgical robotics being developed by Cambridge Medical Robotics as part of the company’s commitment to developing the next generation of world class engineers and scientists.

Cambridge Medical Robotics (CMR) recently announced that it had created the Versius surgical robotic system to perform minimally invasive abdominal surgery. CMR’s mission is to make surgical robotics commonplace in every hospital by providing a cost-effective, flexible, next-generation solution capable of carrying out the vast majority of minimal access procedures. The company is rapidly progressing towards manufacturing scale up and market introduction.

Luke Hares, technology director of CMR, said: “As a child, I remember taking apart an old-fashioned typewriter and unwittingly became hooked on understanding how things work and how I could improve them. I’ve subsequently enjoyed a fascinating career doing just that. Hopefully today’s visit has stimulated another group of young people to be curious enough to ask why something is the way it is and passionate enough to want to improve the status quo.”




For further information, please contact:

Cambridge Medical Robotics
Patrick Pordage
Head of Marketing
Tel: +44 (0) 1223 755 388


About Cambridge Medical Robotics Limited

Cambridge Medical Robotics is developing a next-generation robotic system for universal keyhole surgery. The Versius system comprises a surgeon console, modular light-weight robotic arms and a range of wristed 5 mm instruments. The system uses state-of-the-art 3D high-definition imagery, significantly enhanced flexibility, and incorporates haptic feedback to provide surgeons with life-like sensitivity.

CMR aims to expand the surgical robotics market by significantly increasing the volume and range of supported procedures, making keyhole surgery universally accessible and affordable.

Versius overcomes obstacles to widespread adoption of robotic minimal access surgery, namely robot size, instrument size, versatility, port placement, cost and ease of use, allowing the system to be highly utilised and ultimately cost-comparable to manual laparoscopic surgery.

Global annual revenues for robotic-assisted keyhole surgery are presently approximately $3.2 billion and are anticipated to reach $20 billion by 2021 (‘Research and Markets’).

The Company was formed in 2014 and has its headquarters in Cambridge, United Kingdom.

For further information please visit: